Account
Inquiry
Retatrutide acetate, also known as LY3437943, is a high-purity peptide agonist targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). With a purity level of 99%, this product is designed for advanced research applications in metabolic studies and weight management.
The semaglutide injection price is competitive for bulk orders, making it an ideal choice for laboratories and institutions engaged in pharmaceutical development. Retatrutide acetate demonstrates potent activity with EC50 values of 5.79 nM for human GCGR, 0.0643 nM for human GIPR, and 0.775 nM for human GLP-1R. In murine models, it shows EC50 values of 2.32 nM for GCGR, 0.191 nM for GIPR, and 0.794 nM for GLP-1R.
In vivo studies indicate that Retatrutide acetate enhances glucose tolerance through GIP or GLP-1 receptor pathways and promotes significant weight reduction by increasing energy expenditure via glucagon receptor activation. This makes it a valuable compound for obesity-related research.
Available in various concentrations including 5mg, 10mg, and 15mg per vial, with packaging options of 10 vials per box. The product is supplied as a white lyophilized powder, ensuring stability and ease of use in research settings. Storage recommendations include keeping the product at 2-8°C in a dry, cool environment to maintain integrity.
This product is intended for research use only and not for human consumption. Customization services such as OEM packaging, labeling, and bulk orders are available to meet specific research requirements. The semaglutide injection price is structured to accommodate both small-scale and large-volume purchases, providing flexibility for diverse research needs.
